ReNeuron Group plc
08 August 2007
NOTIFICATION OF TRANSACTIONS OF DIRECTORS,
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating
to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,
16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should
complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other than a
debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16,
23 and 24.
Please complete all relevant boxes in block capital letters.
1. Name of the issuer
RENEURON GROUP PLC
2. State whether the notification relates to (i) a transaction
notified in accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324
(as extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
A TRANSACTION NOTIFIED IN ACCORDANCE WITH DR 3.1.4R(1)(A).
3. Name of person discharging managerial responsibilities/director
MICHAEL HUNT-DIRECTOR
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify
the connected person
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
8. State the nature of the transaction
9. Number of shares, debentures or financial instruments relating to shares
acquired
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
11. Number of shares, debentures or financial instruments relating to shares
disposed
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
13. Price per share or value of transaction
14. Date and place of transaction
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
16. Date issuer informed of transaction
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17. Date of grant
7 AUGUST 2007
18. Period during which or date on which it can be exercised
10 YEARS FROM THE 7 AUGUST 2007 SUBJECT TO PERFORMANCE CONDITIONS
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
1,000,000 ORDINARY SHARES
21. Exercise price (if fixed at time of grant) or indication that price is
to be fixed at the time of exercise
500,000 ORDINARY SHARES AT AN EXERCISE PRICE OF 21 PENCE PER SHARE; AND
500,000 ORDINARY SHARES AT AN EXERCISE PRICE OF 37.5 PENCE PER SHARE.
22. Total number of shares or debentures over which options held following
notification
3,400,000 ORDINARY SHARES
(INCLUDING ALL PREVIOUS OPTIONS)
23. Any additional information
GRANTED UNDER THE RULES OF THE EMPLOYEE SHARE OPTION SCHEME.
24. Name of contact and telephone number for queries
MICHAEL HUNT
CHIEF EXECUTIVE OFFICER
PH: +44(0) 1483302560
Name and signature of duly authorised officer of issuer responsible for
making notification
Date of notification
8/8/07
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.